prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |review
The evidence presented in the last three slides represents only a very small fraction of the enormous amount of toxicity data on endocrine disruption. Neither are the few studies all that representative of the most relevant collection of the work done on the subject today. Yet the literature data provided here appear to have carried the collective weight of evidence for biologic plausibility and consistency, which are the two most crucial criteria for establishing a causal relationship. These limited data thus collectively are still considered as providing sufficient evidence for the concern that certain environmental endocrine disruptors (EEDs) can be toxic and potent, and that their disruption effects in humans and wildlife can be severe.

In closing this first chapter (part), it is important to note that from a public health standpoint, a disruptor’s toxicity or potency is the lesser important of the two key components of a health risk. The other key component tends to offer more preventive measures and hence appears to play a greater role, in that it counts on the disruptor’s availability for exposure. A chemical’s availability, especially that of an EED, is measured by its usage, its persistence, and the potential for its bioaccumulation by organisms in an ecosystem. Though often not considered as the most desirable, an effective or complete prevention or mitigation measure is of course to ban the chemical in question.

Whether or not a chemical’s production and use should be banned or substantially reduced depends primarily on its toxicity, persistence, and bioaccumulation properties. Part I here has just presented the general toxicity of EEDs. Their bioaccumulation and persistence properties are the topics of extensive discussion given in Part II and Part III, respectively.

 
Go to Comment Form